Study Set Content:
possesses an antigenic value not less than that of N.I.H. Inaba strain 35-A-3
Inaba Strain
possesses an antigenic value not less than that of N.I.H. Ogawa strain 41
Ogawa strain
stored at a temperature between () and the expiration date is not longer than () from the date of issue
2 and 8°C, 18 months
sterile suspension, in an isotonic sodium chloride solution or other suitable diluent, of killed plague bacilli
(Yersinia pestis)
bacteria causing bubonic and pneumonic plague in humans are named Yersinia in honor of the Swiss bacteriologist (), who was the first to isolate and identify the disease causing organism
Yersin
() serve as an animal reservoir for the organisms, but the disease is transmitted to humans through the bites of ()
Rats, fleas
Its use is generally restricted to travelers to known plague areas, including
Mongolia, southwestern Russia, central China, India,Pakistan, Nepal, Indonesia, Vietnam, South Africa, Saudi Arabia, Brazil, Bolivia, and Peru
Pertussis vaccine sterile bacterial fraction or suspension of killed
pertussis bacilli
pertussis bacilli
(Bordetella pertussis)
stored at a temperature between () and must be protected against freezing; expiration date is not later than () from the date of issue
2 and 8°C, 18 months
Bordetella pertussis is the organism that causes the disease known as
whooping cough or pertussis.
dried, living culture of the bacillus Calmette-Guérin stra
BCG VACCINE
dried, living culture of the bacillus Calmette-Guérin strain of
Mycobacterium tuberculosis var. bovis
iration date of BCG vaccine is up to
1 year
expiration date of BCG vaccine is up to 1 year if it is stored at
5°C
active immunizing agent against tuberculosis
BCG VACCINE
contain the specific bacterial capsular polysaccharides for Neisseria meningitidis Serogroups A, C, Y, and W-135
MENINGOCOCCAL POLYSACCHARIDE VACCINES
The use of meningococcal polysaccharide vaccine is indicated for children over () of age and for () and adult populations at risk in ()
2 years, military recruits , epidemic areas.
protection against the 23 most prevalent capsular types of pneumococci
PNEUMOCOCCAL VACCINE POLYVALENT
PNEUMOCOCCAL VACCINE POLYVALENT prepared by isolating and purifying the polysaccharide antigens from strains of
Streptococcus pneumoniae
